Gnpx investor relations
WebApr 13, 2024 · AUSTIN, Texas , March 23, 2024 /PRNewswire/ -- Rodney Varner , CEO of Genprex, Inc. ("Genprex" or the "Company") (Nasdaq: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today commended The U.S. Food and Drug Administration's (FDA) initiative … WebFind the latest Genprex, Inc. (GNPX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Gnpx investor relations
Did you know?
WebFeb 9, 2024 · Investor Relations GNPX Investor Relations (877) 774-GNPX (4679) ext. #2 [email protected] Media Contact Genprex Media Relations Kalyn Dabbs (877) 774-GNPX (4679) ext. #3 [email protected] ... WebMay 5, 2024 · (877) 774-GNPX (4679) GNPX Investor Relations [email protected] GNPX Media Contact Kalyn Dabbs [email protected] SOURCE Genprex, Inc.
WebFeb 27, 2024 · (877) 774-GNPX (4679) GNPX Investor Relations [email protected] GNPX Media Contact Kalyn Dabbs [email protected] SOURCE Genprex, Inc. WebApr 11, 2024 · 1 brokerages have issued 12 month price targets for Genprex's stock. Their GNPX share price forecasts range from $3.00 to $3.00. On average, they anticipate the …
WebApr 20, 2024 · Genprex, Inc. (877) 774-GNPX (4679) Investor Relations GNPX Investor Relations (877) 774-GNPX (4679) ext. #2 [email protected] Media Contact Genprex Media Relations Kalyn Dabbs (877) 774-GNPX ... WebWe’re passionate about the work we’re doing to fight cancer and diabetes, and we want to keep our current and potential investors informed on our day-to-day advancements. For … GNPX Investor Relations. (877) 774-GNPX (4679) ext. #2. …
WebMar 24, 2024 · Event: Oncology Investor Conference (Virtual) Date: The conference will take place virtually March 29 - April 2, 2024 Presentation Date: Monday, March 29 Presentation Time: 2 p.m. Eastern Daylight ...
WebFeb 27, 2024 · Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. Genprex undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Genprex, Inc. (877) 774-GNPX (4679) psychiatric modifiers cpt codeWebFeb 9, 2024 · AUSTIN, Texas — (Feb. 9, 2024) — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its President and Chief Executive Officer, Rodney Varner, will provide an overview of … psychiatric movementsWebAUSTIN, Texas — (January 5, 2024) — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced it has entered into an exclusive license agreement (the Agreement) with the University of Pittsburgh ... hoseasons manchesterWebMar 8, 2024 · (877) 774-GNPX (4679) GNPX Investor Relations [email protected]. GNPX Media Contact Kalyn Dabbs [email protected] ... hoseasons map searchWebAug 15, 2024 · (877) 774-GNPX (4679) GNPX Investor Relations [email protected] GNPX Media Contact Kalyn Dabbs [email protected] SOURCE Genprex, Inc. hoseasons manor parkWebGNPX Stock Price - Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s … psychiatric mother and baby unitWebMar 8, 2024 · Event: 35 th Annual Roth Conference Conference Date: March 12-14, 2024 Location: The Ritz-Carlton, Laguna Niguel, Dana Point, California In attendance at the Roth Conference will be Genprex's Chief Financial Officer, Ryan Confer.For those interested in meeting Mr. Confer during the Roth Conference, please request a meeting through the … psychiatric movies list